Tag: Prescription Drugs

Variability seen in viral load coverage and in viral load suppression among distinct subpopulations

Multifaceted intervention of assessment, education, and feedback increases likelihood of triple prescription fourfold over usual care

Approval of Daybue applies to adults and children aged 2 years and older

For patients with recurrent kidney stones, no difference seen in recurrence with hydrochlorothiazide 12.5, 25, 50 mg versus placebo

Significant progression-free survival benefit seen over placebo; more patients receiving nirogacestat have objective response

Incidence of symptom rebound was higher in the nirmatrelvir plus ritonavir treatment group

FDA has been proposing to remove Makena from the market since October 2020, a decision appealed by the drug maker

Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo

Stimulated C-peptide secretion partially preserved with verapamil versus placebo at 52 weeks after diagnosis of type 1 diabetes

More than half of U.S. abortions in 2020 were completed by medication instead of surgery